AlloVir, Inc. (ALVR) has an overall financial health rating of C- with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2025-03-18.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-03-18 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-03-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-03-14 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-03-13 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-03-12 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-03-11 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-03-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-03-07 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-03-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-03-05 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-03-04 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-03-03 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
